Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Agios Pharmaceuticals (AGIO) Receivables - Net (2016 - 2021)

Agios Pharmaceuticals (AGIO) has disclosed Receivables - Net for 8 consecutive years, with $4.4 million as the latest value for Q4 2021.

  • For Q4 2021, Receivables - Net changed N/A year-over-year to $4.4 million; the TTM value through Dec 2021 reached $4.4 million, changed N/A, while the annual FY2021 figure was $4.4 million, 106.22% up from the prior year.
  • Receivables - Net hit $4.4 million in Q4 2021 for Agios Pharmaceuticals, up from $2.3 million in the prior quarter.
  • Across five years, Receivables - Net topped out at $19.3 million in Q2 2018 and bottomed at $779000.0 in Q2 2017.
  • Average Receivables - Net over 5 years is $3.7 million, with a median of $2.5 million recorded in 2019.
  • Year-over-year, Receivables - Net skyrocketed 2380.87% in 2018 and then crashed 86.94% in 2019.
  • Agios Pharmaceuticals' Receivables - Net stood at $2.4 million in 2017, then rose by 0.57% to $2.5 million in 2018, then plummeted by 37.49% to $1.5 million in 2019, then skyrocketed by 51.66% to $2.3 million in 2020, then skyrocketed by 87.57% to $4.4 million in 2021.
  • According to Business Quant data, Receivables - Net over the past three periods came in at $4.4 million, $2.3 million, and $2.5 million for Q4 2021, Q3 2020, and Q2 2020 respectively.